Experts discuss latest guidelines and how novel treatments can reduce ASCVD risk in patients with dyslipidemias episode artwork

EPISODE · Oct 11, 2022 · 30 MIN

Experts discuss latest guidelines and how novel treatments can reduce ASCVD risk in patients with dyslipidemias

from touchPODCAST · host touchpodcast

touchIN CONVERSATION for touchCARDIO Listen to Prof. Kausik Ray in conversation with Dr Mahir Karakas. They respond to questions submitted by the HCP audience and provide their expert insights on how the latest guidelines and treatments can be applied to reduce ASCVD risk in patients with dyslipidemias.    This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical educational grant from Novartis. This activity is provided by  touchIME.   For further information visit our website: https://touchendocrinologyime.org/in-conversation-guidelines-novel-therapies-emerging-options-for-managing-dyslipidemias-ASCVD-risk

Episode metadata supplied by the publisher feed · Published Oct 11, 2022

Embed this episode

Ready to play

Experts discuss latest guidelines and how novel treatments can reduce ASCVD risk in patients with dyslipidemias

0:00 30:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 30 minutes long.

When was this touchPODCAST episode published?

This episode was published on October 11, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!